Nicholos Joseph: Superbugs are a major threat. Washington should prioritize antibiotic development now

  14 April 2022

We don’t know when the next pandemic will strike. But we have a good idea of where it’ll start — in hospitals.

Bacteria and fungi are constantly evolving and growing more and more resilient to the antibiotics we use to treat them. These “superbugs” will eventually mutate to resist even our last-line-of-defense treatments.

When that happens, these microscopic killers could spread from room to room within hospitals and eventually out into the world. Today, these “superbugs” — resistant to the most potent treatments we have — pose a threat during procedures ranging from organ transplants to routine childbirth. And the problem continues to grow at a pace faster than we can innovate. Even minor scrapes and cuts could ultimately prove fatal if we do not act now.

Today, antibiotic resistance kills more people around the world than HIV or malaria. If left unaddressed, superbugs are on track to kill a staggering 10 million people annually by 2050, unless scientists develop new and improved treatments that keep pace with these ever-evolving microbes.

Further reading: Chicago Tribune
Author(s): Nicholos Joseph
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed